Imaging Techniques for Intracranial Hemorrhage
(SPINNERS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Non-contrast cranial MDCT head scan and related imaging techniques for intracranial hemorrhage?
Research shows that advanced imaging techniques like Syngo DynaCT and Sine Spin FDCT improve image quality by reducing artifacts, which can help in better diagnosing and managing brain conditions. These techniques have been effective in detecting complications during neuroendovascular procedures, suggesting they could be useful for identifying intracranial hemorrhages.12345
Is the imaging technique for intracranial hemorrhage safe for humans?
How does the Non-contrast syngo DynaCT Sine Spin head scan treatment differ from other treatments for intracranial hemorrhage?
The Non-contrast syngo DynaCT Sine Spin head scan is unique because it uses a flat detector CT (FDCT) with a double oblique trajectory to reduce image artifacts and improve soft tissue imaging, offering better image quality compared to traditional CT scans. This advanced imaging technique allows for clearer visualization of the brain, which can be crucial in diagnosing and managing intracranial hemorrhage.12346
What is the purpose of this trial?
Stroke is one of the leading causes of mortality and disability worldwide. Optimization of intra-hospital pathways is as of today one of the most promising research topics in stroke treatment. A potential solution to shorten the time needed for current workflows, and therefore reperfusion, is to do both imaging and subsequent endovascular therapy (EVT) in the angiography suite using non-contrast syngo DynaCT Sine Spin (FDCT) for the exclusion of intracranial hemorrhage and flat detector CT angiography (FDCTA) or digital subtraction angiography for diagnosis of LVO. It is still a matter of debate if FDCT can reliably differentiate between ischemic and hemorrhagic stroke.This study aims to investigate if non-contrast syngo DynaCT Sine Spin imaging is non-inferior to non-contrast MDCT imaging regarding its sensitivity and specificity for the detection of intracranial hemorrhages.
Research Team
Marios-Nikos Psychogios, Prof Dr
Principal Investigator
University Hospital, Basel, Switzerland
Adam S Arthur, MD, MPH
Principal Investigator
Semmes Murphey Clinic and University of Tennessee Health Sciences Center
Eligibility Criteria
This trial is for adults over 18 with symptoms of a stroke, who can give informed consent and arrive at the hospital within 24 hours of their last known well time. They should be able to have two types of head scans within four hours. It's not suitable for those who don't meet these timing or consent requirements.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo a non-contrast MDCT scan followed by a non-contrast syngo DynaCT Sine Spin head scan
Follow-up
Participants are monitored for adverse device events and the occurrence of intracranial hemorrhages
Treatment Details
Interventions
- Non-contrast cranial MDCT head scan
- Non-contrast syngo DynaCT Sine Spin head scan and application software
Non-contrast syngo DynaCT Sine Spin head scan and application software is already approved in European Union, United States for the following indications:
- Detection of intracranial hemorrhage
- Detection of intracranial hemorrhage
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Hospital, Basel, Switzerland
Lead Sponsor
Siemens Healthineers AG
Collaborator